Basic and preclinical experiments of IL 8 and MCAF

IL 8和MCAF的基础和临床前实验

基本信息

  • 批准号:
    03044066
  • 负责人:
  • 金额:
    $ 6.4万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for international Scientific Research
  • 财政年份:
    1991
  • 资助国家:
    日本
  • 起止时间:
    1991 至 1992
  • 项目状态:
    已结题

项目摘要

BASIC AND PRECLINICAL EXPERIMENTS OF IL 8 AND MCAFNovel chemotactic cytokines, IL 8 and MCAF were identified, purified, and molecularly cloned by us at National Cancer Institute, USA in 1987-1989, belong a family of emerging chemotactic cytokine family, CHEMOKINE. In this international collabolative research, the following projects were performed.1)Structural analysis of IL 8/MCAF and determining their active site(s)-----Human IL 8 was expressed in E coli and purified to homogeneity in a large scale. The structure of IL 8 was analyzed by both NMR and X-ray crystallography. The proposed model shows that IL 8 exists as dimer through hydrogen bonding and two symmetry-related anti-parallel a-helices, 24A long and separated by 14A, lie on top of a six-stranded anti-parallel b-sheet platform. The active site of IL 8 was presumed to be the region surrounding His at 33 as well as N-terminal region based on the mutation studies and structural analyses.2)Structure of the receptors for IL 8 and M … More CAF-----The MW of the receptors for IL 8 on human nutrophils was estimated to be 60,000 with Kd of lnM. The MW of the receptors for MCAF on human monocytes was estimated to be 40,000 with Kd of 25nM. Although the cDNA for IL 8 was cloned by other groups, we have cloned several novel cDNA which belong to the family of chemotactic cytokine receptors.3)Molecular analysis of the regulation of the production of IL 8-----After cDNA cloning of human IL 8, we revealed the induction of the production of IL 8 by various types of cells after stimulating with IL 1, TNF, endotoxin, exotoxin, viral proteins, heavy metals, and superoxide generating substances. We also showed the suppression of the production of IL 8 by glucocorticoids, vitamin D3, lipooxygenase inhibitors, and FK506. We have determined the enhancer of the human IL 8 gene to be consisted of AP-1+NFKB. IL 8 production suppressive agents seem to inhibit the activation of nuclear factors which bind to these regions.4)Establishment of pathophysiological roles of IL 8/MCAF and examining possible clinical application of IL 8/MCAF-----We have revealed the production of IL 8/MCAF in various human inflammatory diseases including ulcerative colitis, psoriasis, glomerulonephritis, urinary tract infection, and arthritis. Essential involvement of IL 8 in recruiting neutrophils in acute inflammation models in rabbits, such as dermatitis, arthritis, and lung reperfusion was established using monoclonal neutralizing antibody against rabbit IL 8. IL 8/MCAF cDNA transfection into tumor cells showed significant anti-tumor effect of these cytokines in mice. MCAF is further shown to prime murine macrophages to be tumor cytocidal and also have anti-infectious activity in mice. Possible hematopoietic activity of these cytokines was not proved either in vitro or in vivo. Less
1987年至1989年,美国在美国国家癌症研究所(National Cancer Institute)在美国国家癌症研究所(National Cancer Institute)鉴定,纯化和分子克隆了IL 8和MCAFNOVEL趋化细胞因子,IL 8和MCAF的基本和临床前实验。在这项国际合作研究中,进行了以下项目。1)IL 8/MCAF的结构分析,并确定其主动地点----人类IL 8在e Coli中表达,并大规模纯化为同质性。通过NMR和X射线晶体学分析了IL 8的结构。提出的模型表明,IL 8通过氢键作为二聚体存在,并且两个与对称相关的抗平行A螺旋长24A,并由14a隔开,位于六链的抗平行B-steet平台的顶部。根据突变研究和结构分析,IL 8的活性位点被预计为围绕33的区域以及N末端区域。2)IL 8和M的受体结构IL 8和M…更多的Caf -----更多的IL受体MW在人类营养区域的受体MW估计为60,000,估计为60,000。人类单核细胞上MCAF的受体MW估计为40,000,KD为25nm。尽管IL 8的cDNA由其他组克隆,但我们克隆了几个属于趋化性细胞因子受体家族的新型cDNA。蛋白质,重金属和超氧化物质。我们还显示了糖皮质激素,维生素D3,脂氧酶抑制剂和FK506抑制IL 8的产生。我们已经确定人IL 8基因的增强子是AP-1+NFKB一致的。 IL 8产量抑制剂似乎抑制了与这些区域结合的核因素的激活。4)建立IL 8/MCAF的病理生理作用,并检查了IL 8/MCAF的可能临床应用 - 我们已经揭示了IL 8/MCAF在各种人类炎症性疾病中的产生,包括各种人类炎症性疾病,包括溃疡性疾病,包括溃疡性炎症,脉络膜炎,脉络膜炎,幼发学,尿布素,尿布素,尿布素,尿布素,尿布素,尿布素。使用单克隆性中和对兔8。IL8/MCAF cDNA转染的抗体,建立了IL 8的急性炎症模型中嗜中性粒细胞的基本参与。 MCAF进一步证明了鼠巨噬细胞为肿瘤巨噬细胞,并且在小鼠中也具有抗感染活性。这些细胞因子的可能造血活性在体外或体内均未证明。较少的

项目成果

期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mahe,Y.: "Hepatitis B virus X protein transactivates human interleukin 8 gene throughhacting on muclear factor KB and CCAAT/enhancer-binding protein-like cise-lementls" J.Biol,Chem.266. 13759-13763 (1991)
Mahe,Y.:“乙型肝炎病毒 X 蛋白通过作用于核因子 KB 和 CCAAT/增强子结合蛋白样顺式元件反式激活人白细胞介素 8 基因”J.Biol,Chem.266。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Smyth, M.J., etal.: "Interleukin 8 gene expression and production in human peripheral blood lymphocyte subset" J.Immunol.146. 3815-3823 (1991)
Smyth, M.J. 等人:“人外周血淋巴细胞亚群中白细胞介素 8 基因的表达和产生”J.Immunol.146。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Oppenheim,J.J., Zachariae,C.O.C., Mukaida,N., Matsushima,K.: "Properties of the novel proinflammatory supergene″intercrine″cytokine family." Annu.Rev.Immunol., 31 (1991)
Oppenheim, J.J.、Zachariae,C.O.C.、Mukaida,N.、Matsushima,K.:“新型促炎超基因“间分泌”细胞因子家族的特性。”Annu.Rev.Immunol.,31(1991)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Oppenheim, J.J. etal.: Annu.Rev.Immunol.Properties of the novel proinflammatory supergene"intercrine"cytokine family, 617-648 (1991)
奥本海姆,J.J.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Baldwin,E.T.: "Crystal structure of interleukin 8" Proc.Natl.Acad.Sci.88. 502-506 (1991)
Baldwin,E.T.:“白细胞介素 8 的晶体结构”Proc.Natl.Acad.Sci.88。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MATSUSHIMA Kouji其他文献

Osteopontin identifies a novel profibrotic population of fibroblasts
骨桥蛋白鉴定出一种新型的促纤维化成纤维细胞群
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    0
  • 作者:
    ABE Jun;SHICHINO Shigeyuki;HASHIMOTO Shin-ichi;SHIMAOKA Takeshi;TOMURA Michio;INAGAKI Yutaka;MATSUSHIMA Kouji
  • 通讯作者:
    MATSUSHIMA Kouji
Delayed and aberrant immune reconstitution due to destruction of hematological and immunological niches in the acute and chronic phases of GVHD
由于 GVHD 急性期和慢性期血液学和免疫学生态位的破坏导致免疫重建延迟和异常
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    野竹剛;瀧伸介;MATSUSHIMA Kouji
  • 通讯作者:
    MATSUSHIMA Kouji
Proposal for the breakdown of increased cancer health care cost and its improvement
关于增加的癌症医疗费用的细分及其改进的建议
  • DOI:
    10.1093/jjco/hyt015
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    2.4
  • 作者:
    野竹剛;瀧伸介;MATSUSHIMA Kouji;鳥谷部真一;Koinuma N
  • 通讯作者:
    Koinuma N
An anti-CD4 depleting antibody induces transient CD80/CD86 up-regulation on dendritic cells in tumor-bearing mice
抗 CD4 耗竭抗体诱导荷瘤小鼠树突状细胞瞬时 CD80/CD86 上调
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    UEHA Satoshi;OGIWARA Haru;SHAND Francis;KAKIMI Kazuhiro;ITO Satoru;MATSUSHIMA Kouji
  • 通讯作者:
    MATSUSHIMA Kouji

MATSUSHIMA Kouji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MATSUSHIMA Kouji', 18)}}的其他基金

Visualization of osteoblast impairments during bone marrow GVHD
骨髓 GVHD 期间成骨细胞损伤的可视化
  • 批准号:
    24659216
  • 财政年份:
    2012
  • 资助金额:
    $ 6.4万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Elucidation of the molecular bases of the generation and maintenance of CTL memory by next generation DNA sequencer
下一代DNA测序仪阐明CTL记忆产生和维持的分子基础
  • 批准号:
    22390095
  • 财政年份:
    2010
  • 资助金额:
    $ 6.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies on molecular mechanisms and therapeutic targets of bone marrow GVHD
骨髓GVHD分子机制及治疗靶点研究
  • 批准号:
    22659095
  • 财政年份:
    2010
  • 资助金额:
    $ 6.4万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Analysis of generation and control mechanism of CD8+ T cells by chemokines
趋化因子对CD8 T细胞产生及控制机制的分析
  • 批准号:
    18209016
  • 财政年份:
    2006
  • 资助金额:
    $ 6.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular dynamics of chemokine receptors in memory T cells
记忆T细胞趋化因子受体的分子动力学
  • 批准号:
    16390143
  • 财政年份:
    2004
  • 资助金额:
    $ 6.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Dynamism of immune cells in immune-tissue formation
免疫细胞在免疫组织形成中的动态
  • 批准号:
    15078203
  • 财政年份:
    2003
  • 资助金额:
    $ 6.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Functional analysis and the molecular mechanism of CCR5 in the CTL induction.
CCR5在CTL诱导中的功能分析及分子机制。
  • 批准号:
    14370108
  • 财政年份:
    2002
  • 资助金额:
    $ 6.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Pathophysiological and pharmacological studies on chemokines
趋化因子的病理生理学和药理学研究
  • 批准号:
    08044263
  • 财政年份:
    1996
  • 资助金额:
    $ 6.4万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Molecular analysis of inflammation and immune response
炎症和免疫反应的分子分析
  • 批准号:
    08457104
  • 财政年份:
    1996
  • 资助金额:
    $ 6.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Humanization of mouse anti-human IL-8 antibody and development of anti-inflammatory agent against cytokine regulatory factor, NFkB
小鼠抗人IL-8抗体的人源化和针对细胞因子调节因子NFkB的抗炎剂的开发
  • 批准号:
    07557031
  • 财政年份:
    1995
  • 资助金额:
    $ 6.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)

相似国自然基金

肝细胞因子ORM2通过抑制Kupffer细胞激活改善非酒精性脂肪性肝炎的作用及机制研究
  • 批准号:
    82300966
  • 批准年份:
    2023
  • 资助金额:
    20 万元
  • 项目类别:
    青年科学基金项目
旋毛虫类细胞因子在侵袭与寄生过程中的功能及其作用机制研究
  • 批准号:
    32373032
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于Mtb特异性细胞因子组合标志物的系统性红斑狼疮患者结核发病风险预测模型构建、验证和应用研究
  • 批准号:
    82373648
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
纳米催化气泡式微流控数字免疫分析法在细胞因子高灵敏即时检测中的研究
  • 批准号:
    22304122
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
动态可编程DNA交联微针用于细胞因子/免疫佐剂智能共递送和抗肿瘤免疫治疗
  • 批准号:
    52303208
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD
一种吸入性微生物组靶向生物治疗药物,用于治疗慢性阻塞性肺病
  • 批准号:
    10600887
  • 财政年份:
    2023
  • 资助金额:
    $ 6.4万
  • 项目类别:
Anti-nucleolin aptamer AS1411: Applications in Kaposi's Sarcoma Associated Herpes Virus (KSHV) biology
抗核仁素适体 AS1411:在卡波西肉瘤相关疱疹病毒 (KSHV) 生物学中的应用
  • 批准号:
    10619191
  • 财政年份:
    2023
  • 资助金额:
    $ 6.4万
  • 项目类别:
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD
一种吸入性微生物组靶向生物治疗药物,用于治疗慢性阻塞性肺病
  • 批准号:
    10917559
  • 财政年份:
    2023
  • 资助金额:
    $ 6.4万
  • 项目类别:
Immune Signatures and Clinical Outcomes in Acute Pancreatitis
急性胰腺炎的免疫特征和临床结果
  • 批准号:
    10568011
  • 财政年份:
    2023
  • 资助金额:
    $ 6.4万
  • 项目类别:
Delirium, Long-Term Cognition and the Dementia Pathological Trajectory
谵妄、长期认知和痴呆病理轨迹
  • 批准号:
    10574994
  • 财政年份:
    2023
  • 资助金额:
    $ 6.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了